U.S. life sciences company Illumina could face a hefty fine for jumping the gun by completing its $8 billion cash-and-stock takeover of cancer detection test maker Grail without first securing EU …
(Orginal – Story lesen…)
Handy News
Werbung
WERBUNG
get your GALAXY Z
